Posted on Leave a comment

Tips & Resources to Reduce Stress During Harvest Season – Morning Ag Clips

PUBLISHED ON
FARGO, N.D. — As harvest season hits the region and families seek to manage their farming efforts in the coming days and weeks, many farmers, farm laborers, agricultural professionals and family members are facing increased stresses linked with uncertain markets and prices, input costs and other factors.
“Taking time to focus on simple wellness practices can aid in managing and reducing such stresses during harvest time,” says Sean Brotherson, North Dakota State University Extension family science specialist.
The emotional and physical needs of those who are undergoing stress from tough conditions in agriculture are sometimes forgotten during efforts to manage farming impacts from external events.
“The hours they must spend in dealing with price concerns, reviewing financial decisions and making farming decisions can be long, stressful and tiring,” says Brotherson.
Individual farmers, ranchers and laborers may not consider their own needs, or they may feel too occupied with other responsibilities to handle personal or family needs.
“Farmers and others working in agriculture sometimes try to be invulnerable to fatigue, stress, frustration and depression,” says Brotherson. “Perhaps the demand on their energies is so great they think they can muddle through.”
However, farmers and other agricultural workers need help, encouragement and assistance in times of higher stress levels.
NDSU Extension has resources on its website (ndsu.ag/managingstress) designed to assist individuals, families and community professionals for managing stress in agriculture.
Farmers, their family members and other agricultural workers need to take care of themselves to have the emotional and physical resources to deal with stresses, says Brotherson:
“Your health is your most important asset on your farm or ranch operation. Taking time daily to invest in your own health through wellness practices is vital during stressful times.”
Brotherson provides a few tips and resources to consider for addressing emotional and physical well-being:
Brotherson also notes a variety of useful resources specifically for farm and ranch family members and others in agriculture to get support or focus on wellness:
–NDSU Agriculture Communication
WEST LAFAYETTE, Ind. — Beekeepers lose between 30% and 40% of their colonies annually, mostly to parasites and pathogens. Losses during one bad year in Indiana reached 60%. “The traditional methods of bee breeding have been around for nearly 100 years,” said Purdue University’s Brock Harpur, assistant professor of entomology. Although breeders have made progress, […]
OAK BROOK, Ill. — In order to strengthen the pipeline for the next generation of food and agriculture leaders, Farm Foundation seeks nominations for two of its premier Next Generation programs. Farm Foundation’s Young Farmer Accelerator and Young Agri-Food Leaders programs are accepting nominations for the 2024 cohorts through March 4, 2024.  Once selected for […]
ST. PAUL, Minn. — The Minnesota Department of Agriculture (MDA) is partnering with three other state agencies and organizations to offer free virtual suicide prevention trainings for rural faith leaders in Minnesota, Wisconsin, North Dakota, and South Dakota. Clergy and lay leaders who serve congregations of all faiths and denominations are welcome. “We recognize that […]
DES MOINES — The National Pork Producers Council (NPPC) and the National Pork Board (NPB) are excited to announce the Class of 2025 for the Pork Leadership Institute (PLI), a premier program dedicated to equipping pork producers with the knowledge and skills to lead the industry into the future. This year, 17 exceptional individuals from […]
American Angus Association Seek 2026 Summer Interns
Beef Prices
PFAS in crops
Nanoparticles in vegetables
CORN STEM CELLS
farmers Economic Outlook
Chocolate Gold

California tree deaths pathogens
Pick your region or specialty and stay in the know.
Free. Fast. Farmer-approved.
Subscribe now → Click here to Subscribe
Photo Contest

source

Posted on Leave a comment

Crypto Payroll: The Future of Work? – OneSafe

As the financial landscape evolves, crypto payroll solutions are becoming increasingly appealing for startups. With stablecoins at the forefront, this shift allows for faster and more efficient payment systems rooted in transparency and decentralization. Let’s dive into how crypto payroll is reshaping startup salaries, the benefits it offers, and the potential pitfalls we need to be aware of.
Crypto payroll means paying employees in cryptocurrencies or stablecoins rather than in traditional fiat currencies. This method is gaining traction, especially among tech and finance startups, because it comes with advantages that traditional payroll systems struggle to match. As digital currencies gain popularity, businesses are finding new ways to streamline payments, cut costs, and keep employees happy.
Stablecoins, pegged to stable assets like the US dollar, are the preferred choice for crypto payroll solutions. They provide the benefits of digital currencies—fast transactions and low fees—without the volatility that typically comes with cryptocurrencies. Using stablecoins allows startups to pay employees predictable and stable salaries, which is a boon for budgeting and financial planning.
Cost Efficiency and Speed: Traditional payroll is often bogged down by high transaction fees and slow processing times. Crypto payroll can cut costs and speed up payment processing, letting startups use resources more effectively.
Increased Financial Inclusion and Flexibility: Crypto payroll is a way to reach employees who may lack access to traditional banking services. By using digital wallets, startups can pay remote workers and freelancers globally, fostering a more diverse workforce.
Ethical Financial Practices: Many startups lean toward crypto payroll because it aligns with their values of transparency and decentralization. By adopting these practices, businesses can build trust with employees and show a commitment to ethical financial management.
But it’s not all sunshine and rainbows. Implementing crypto payroll does come with challenges. Regulatory compliance is a major concern, as governments try to figure out how to regulate cryptocurrencies. Startups need to navigate complex legal frameworks to ensure they meet tax obligations and follow labor laws.
Volatility in the cryptocurrency market also poses risks. While stablecoins reduce some of this volatility, companies must have plans to manage potential price swings and ensure fair compensation for employees.
Some startups have successfully adopted crypto payroll, showing what’s possible. For example, tech companies using stablecoin payments have sped up payroll processes and cut costs. These early adopters offer a roadmap for others considering crypto payroll.
As the work landscape shifts, crypto payroll solutions will likely play a central role in shaping payment methods. By embracing stablecoins and decentralized finance practices, startups can boost efficiency, promote financial inclusion, and align with ethical values. While challenges remain, the potential for innovation is significant, opening the door to a new era of payroll that reflects the changing dynamics of the global economy.
In the end, the future of payroll isn’t just about new technologies; it’s about rethinking work, compensation, and sustainability in the digital age.

Get started with Crypto effortlessly. OneSafe brings together your crypto and banking needs in one simple, powerful platform.
Ethereum's price volatility poses risks for crypto payroll integration in startups. Explore strategies to manage these challenges and ensure compliance.
Discover how crypto payroll and stablecoins are revolutionizing salary payments for startups, enhancing efficiency and financial inclusion in the digital age.
Ethereum's price may soar to $6,800, driven by market volatility, upgrades, and bullish sentiment. Discover key investment strategies for navigating this dynamic landscape.
Begin your journey with OneSafe today. Quick, effortless, and secure, our streamlined process ensures your account is set up and ready to go, hassle-free

source

Posted on Leave a comment

Chattanooga Powerball player wins $50,000 – Local 3 News

Chattanooga
Mostly Cloudy
H 82°
L 67°
80°
Altamont
Sunny
H 85°
L 70°
85°
Athens
Mostly Cloudy
H 87°
L 64°
87°
Benton
Mostly Cloudy
H 83°
L 67°
79°
Chatsworth
Mostly Cloudy
H 83°
L 67°
79°
Cleveland
Light Rain with Thunder
H 87°
L 63°
71°
Dalton
Thunderstorm
H 87°
L 66°
68°
Dayton
Light Rain with Thunder
H 73°
L 64°
74°
Dunlap
Mostly Cloudy
H 83°
L 67°
79°
Murphy
Mostly Cloudy
H 87°
L 64°
87°
Pikeville
Light Rain with Thunder
H 73°
L 64°
74°
Scottsboro
Thunder in the Vicinity
H 85°
L 63°
86°
Summerville
Light Rain with Thunder
H 90°
L 67°
88°
Ringgold
Mostly Cloudy
H 83°
L 67°
79°
Trenton
Mostly Cloudy
H 83°
L 67°
79°
Chattanooga
Mostly Cloudy
H 82°
L 67°
80°
Altamont
Sunny
H 85°
L 70°
85°
Athens
Mostly Cloudy
H 87°
L 64°
87°
Benton
Mostly Cloudy
H 83°
L 67°
79°
Chatsworth
Mostly Cloudy
H 83°
L 67°
79°
Dalton
Thunderstorm
H 87°
L 66°
68°
Dayton
Light Rain with Thunder
H 73°
L 64°
74°
Dunlap
Mostly Cloudy
H 83°
L 67°
79°
Murphy
Mostly Cloudy
H 87°
L 64°
87°
Pikeville
Light Rain with Thunder
H 73°
L 64°
74°
Summerville
Light Rain with Thunder
H 90°
L 67°
88°
Ringgold
Mostly Cloudy
H 83°
L 67°
79°
Trenton
Mostly Cloudy
H 83°
L 67°
79°

Digital Producer/Weekend Assignment Editor
The Tennessee Lottery announced that a person in Chattanooga won $50,000 by matching four numbers plus the Powerball Saturday.
They held the drawing Saturday, Sept. 20. 
Kanku’s Express gas station on Shallowford Road sold the lucky winning ticket.
No further information is available until the prize is claimed.
Digital Producer/Weekend Assignment Editor
{{description}}
Email notifications are only sent once a day, and only if there are new matching items.
Local 3 News (@local3news) • Instagram photos and videos
Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:
Get up-to-the-minute news sent straight to your device.

source

Posted on Leave a comment

🚨 Crypto Scams Are Everywhere 🚨 Those “get rich quick” crypto investments? They might be traps. Scammers use fake apps, Ponzi schemes, and flashy promises to steal your money. Watch this reel to learn how these scams work and how to protect yourself – LinkedIn

Agree & Join LinkedIn
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
3,365 followers
🚨 Crypto Scams Are Everywhere 🚨 Those “get rich quick” crypto investments? They might be traps. Scammers use fake apps, Ponzi schemes, and flashy promises to steal your money. Watch this reel to learn how these scams work and how to protect yourself before you invest a single penny 💸 #cryptoscam #cryptocurrency #cyberesecurity #infosec
To view or add a comment, sign in
3,365 followers
Create your free account or sign in to continue your search

or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn?
or
New to LinkedIn?
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

source

Posted on Leave a comment

Is Pi Network’s Price Set to Surge Today ? – investx.fr

Despite the recent price correction of Pi Coin, technical indicators suggest an imminent rebound for this cryptocurrency. While the overall crypto market has seen a remarkable uptrend, Pi has appeared to lag behind. However, savvy investors see this as an intriguing entry opportunity before a potential return to key levels.
Written by Charles Ledoux
Translated on July 15, 2025 at 15:30 by Marie
While most cryptocurrencies have recorded double-digit gains in recent weeks, the Pi Coin has fallen by more than 11% from its monthly high. This underperformance can be explained by several factors, notably the continuous token unlocks inflating supply, as well as concerns surrounding the centralization of the Pi Network.
|| July 2025 ||

Monthly Unlock Pi Data in 2025, Pi Network.#PiNetwork #pinetwork24x7 #Pioneers $pi #picoin pic.twitter.com/cjge0NZ8ZX
Indeed, PiScan data reveals that the network will unlock more than 145 million tokens by the end of the month, representing a value of 67 million dollars. Furthermore, the fact that the Pi Foundation holds more than 33 billion dollars in tokens without independent auditing raises concerns about the project’s decentralization.
Despite this recent decline, Pi Coin’s technical indicators suggest an imminent trend reversal. The cryptocurrency has notably formed a double bottom at a support level of $0.4056, with upside potential to $1.666. Additionally, a bearish wedge pattern and a bullish MACD divergence suggest an upcoming price acceleration. However, PI could still drop to $0.43 in the short term.
Thus, although this cryptocurrency has underperformed the rest of the market in recent weeks, savvy investors see it as an interesting entry opportunity. The $0.4056 threshold represents a critical support level to watch closely to confirm the long-term bullish trend.
While Pi Coin’s volatility and volumes have fallen in recent months, this could signify an accumulation phase before a future acceleration. The POC at $0.47 could indicate this trend if the level is quickly reclaimed.
In conclusion, investors betting on a token rebound would benefit from a favorable buying window, with substantial upside potential if key technical levels are successfully breached.
Get $20 when you buy your first tokens on Bybit exchange right now :
More on this topic :
Charles Ledoux is a Bitcoin and blockchain technology specialist. A graduate of the Crypto Academy, he has been a Bitcoin miner for over a year. He has written numerous masterclasses to educate newcomers to the industry and has authored over 2,000 articles on cryptocurrency. Now, he aims to share his passion for crypto through his articles for InvestX.

DISCLAIMER
This article is for informational purposes only and should not be considered as investment advice. Trading cryptocurrencies involves risks, and it is important not to invest more than you can afford to lose.
InvestX is not responsible for the quality of the products or services presented on this page and cannot be held liable, directly or indirectly, for any damage or loss caused by the use of any product or service featured in this article. Investments in crypto assets are inherently risky; readers should conduct their own research before taking any action and invest only within their financial means. This article does not constitute investment advice.
Risk Warning : Trading financial instruments and/or cryptocurrencies carries a high level of risk, including the possibility of losing all or part of your investment. It may not be suitable for all investors. Cryptocurrency prices are highly volatile and can be influenced by external factors such as financial, regulatory, or political events. Margin trading increases financial risks.
CFDs (Contracts for Difference) are complex instruments with a high risk of rapid capital loss due to leverage. Between 74% and 89% of retail investor accounts lose money when trading CFDs. You should assess whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Before engaging in financial or cryptocurrency trading, you must be fully informed about the associated risks and fees, carefully evaluate your investment objectives, level of experience, and risk tolerance, and seek professional advice if needed. InvestX.fr and the InvestX application may provide general market commentary, which does not constitute investment advice and should not be interpreted as such. Please consult an independent financial advisor for any investment-related questions. InvestX.fr disclaims any liability for errors, misinvestments, inaccuracies, or omissions and does not guarantee the accuracy or completeness of the information, texts, graphics, links, or other materials provided.
Some of the partners featured on this site may not be regulated in your country. It is your responsibility to verify the compliance of these services with local regulations before using them.
© InvestX 2025

source

Posted on Leave a comment

Pi Coin Price Set To Drop Below $0.30 This Month: Which Smart Alternatives Could Produce Record-Breaking Returns? – TechFinancials

Get the latest technology news from TechFinancials News about FinTech, Tech, Business, Telecoms and Connected Life.



Pi Coin price has shown signs of weakness lately, and many traders believe PI could slip below $0.30 this month if current support does not hold. Forecasts warn that PI may decline toward $0.25 to $0.30 zones, especially under pressure from weak volume and macro headwinds. 
As the Pi Coin price outlook turns bearish, smart alternatives are getting more attention. Remittix is rising in interest, seen by some as the alternative that could produce record breaking returns if Pi falters.

Pi is trading around $0.36, holding just above recent support near $0.34. Technical analysts point out that if Pi drops below $0.34, it may target $0.30 to $0.32, or if selling intensifies, $0.25 or lower. 
On the upside, PI still has resistance in the $0.36 to $0.37 range. If that zone is reclaimed, there could be a short term bounce. But many models are bearish for the month ahead due to token unlock pressure and weak trading volume. PI’s monthly performance is mixed, with slight gains but no conviction.


Remittix offers a contrast to Pi Coin price risks. Whereas PI is facing potential downward pressure toward $0.30 or below, Remittix is emerging with features that make it attractive at this moment. 
Investors watching Pi Coin price drop scenarios are increasingly considering RTX as the alternative that could generate record breaking returns. Remittix is not just speculative; the project brings a toolkit and metrics that address utility, security, and growth.
Remittix is verified by CertiK and is ranked number one among pre-launch tokens on CertiK’s platform. The beta wallet is now live, enabling crypto to bank transfers in over 30 countries. The project has raised over $26.2 million, sold over 667 million RTX tokens, and its token is priced at $0.1080. 
Remittix has secured two centralized exchange listings after surpassing $20 million and $22 million funding milestones, and the team is preparing for a third listing.
Here are reasons Remittix stands out as the smart alternative right now:
Pi Coin price seems to be edging toward a break below $0.30, contingent on the failure of key support and rising selling pressure. Traders concerned by PI’s weak momentum may decide to shift into assets with clearer utility. 
Remittix is positioned as that asset for many, verified, useful, well funded, and primed for growth. Remittix may be the smart alternative that offers record breaking returns at a moment when Pi Coin price looks vulnerable.
Discover the future of PayFi with Remittix by checking out their project here:
Website: https://remittix.io/   
Socials: https://linktr.ee/remittix   
$250,000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway
 









JSE listed Balwin Properties, a developer that cares about environmentally responsible building practices and the…
Get the latest tech news from TechFinancials about telecoms, fintech and connected life.



TechFinancials delivers in-depth analysis of tech, digital revolution, fintech, e-commerce, digital banking and breaking tech news.
Type above and press Enter to search. Press Esc to cancel.

source

Posted on Leave a comment

Myfembree: Uses, dosage, side effects, cost, and more – Medical News Today

Myfembree (relugolix/estradiol/norethindrone) is a brand-name prescription medication. It’s FDA-approved to manage heavy periods caused by uterine fibroids. These fibroids are growths on or in the uterus that aren’t cancer.
Myfembree is prescribed to adult females* who haven’t yet gone through menopause.
It’s important to note that Myfembree shouldn’t be taken for longer than 24 months. This is because the medication may cause bone loss that can’t be reversed.†
* Sex and gender exist on spectrums. Use of the term “female” in this article refers to sex assigned at birth.
† For more information about bone loss, see “Side effect details” in the “Myfembree side effects” section below.

Myfembree comes as an oral tablet that contains three different active ingredients:
Myfembree comes in one strength. Each tablet contains 40 milligrams (mg) of relugolix, 1 mg of estradiol, and 0.5 mg of norethindrone.
The Food and Drug Administration (FDA) approved Myfembree in May 2021. The drug is the first oral medication taken once daily to manage heavy periods caused by uterine fibroids in adult females who haven’t gone through menopause.
For information about the effectiveness of Myfembree, see the “Myfembree uses” section below.
Myfembree is available only as a brand-name medication. It’s not currently available in generic form.
A generic drug is an exact copy of the active drug in a brand-name medication. Generics usually cost less than brand-name drugs.
The Food and Drug Administration (FDA) approves prescription drugs such as Myfembree to treat certain conditions. Myfembree may also be used off-label for other conditions. Off-label prescribing is when a drug is prescribed for a purpose other than its FDA-approved use.
Myfembree is FDA-approved to manage heavy periods caused by uterine fibroids. The drug is for use in adult females* who haven’t yet gone through menopause.
* Sex and gender exist on spectrums. Use of the term “female” in this article refers to sex assigned at birth.
Uterine fibroids are growths on or in the walls of the uterus that aren’t cancer. The uterus is an organ in the pelvis where a fetus develops during pregnancy.
Uterine fibroids are common in females who are able to become pregnant. Fibroids are made up of smooth muscle tissue. They range from 1 millimeter (mm) to 20 centimeters (cm) in diameter or larger. As a comparison, 20 cm is about the size of a grapefruit.
With uterine fibroids, some people have no symptoms while others have severe symptoms. It depends on the location, size, and number of fibroids present. Common symptoms can include:
Myfembree is approved to manage heavy periods caused by uterine fibroids. For help managing other symptoms related to uterine fibroids, such as constipation, talk with your doctor.
It’s important to note that doctors typically will not prescribe Myfembree treatment for longer than 24 months. This is because the medication may cause bone loss that can’t be reversed. (To learn more about this bone loss, see “Side effect details” in the “Myfembree side effects” section below.)
Clinical studies have shown that Myfembree is an effective treatment for heavy periods caused by uterine fibroids. For information about how the drug performed in clinical studies, see Myfembree’s prescribing information.
You can also learn additional facts about periods and more by visiting our female health hub.
Myfembree is only approved for use in adult females. It isn’t known if the drug is safe or effective for children.
Myfembree can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Myfembree. These lists do not include all possible side effects.
For more information about the possible side effects of Myfembree, talk with your doctor or pharmacist. They can give you tips on how to manage any side effects that may be concerning or bothersome.
Note: The Food and Drug Administration (FDA) tracks side effects of drugs it has approved. If you would like to notify the FDA about a side effect you’ve had with Myfembree, you can do so through MedWatch.
Mild side effects* of Myfembree can include:
Most of these side effects may go away within a few days to a couple of weeks. But if they become more severe or don’t go away, talk with your doctor or pharmacist.
* This is a partial list of mild side effects from Myfembree. To learn about other mild side effects, talk with your doctor or pharmacist, or refer to Myfembree’s prescribing information.
† For more information about this side effect, see “Side effect details” below.

Serious side effects from Myfembree aren’t common, but they can occur. Call your doctor right away if you have serious side effects. Call 911 or your local emergency number if your symptoms feel life threatening or if you think you’re having a medical emergency.
Serious side effects and their symptoms can include:
* For more information about this side effect, see “Side effect details” below.
Myfembree has a boxed warning for this side effect. A boxed warning is the most serious warning from the FDA. It alerts doctors and patients about drug effects that may be dangerous.

If you or someone you know is in crisis and considering suicide or self-harm, please seek support:
If you’re calling on behalf of someone else, stay with them until help arrives. You may remove weapons or substances that can cause harm if you can do so safely.
If you’re not in the same household, stay on the phone with them until help arrives.
Here’s some detail on certain side effects this drug may cause.
Myfembree has a boxed warning about blood clots and blood vessel disorders. A boxed warning is the most serious warning from the FDA. It alerts doctors and patients about drug effects that may be dangerous.
Two of Myfembree’s active ingredients are hormones. Estradiol is a type of estrogen, and norethindrone is a type of progestin (a synthetic form of progesterone). Drugs that contain these hormones are known to cause an increased risk of blood clots and serious cardiovascular problems. “Cardiovascular” refers to the heart and blood vessels.
Rarely, Myfembree may cause blood clots.* Specific types of blood clots that may occur include deep vein thrombosis (DVT) and pulmonary embolism (PE). Blood clots can cause serious cardiovascular problems such as a heart attack or stroke.
Some people may have an increased risk of developing blood clots and related cardiovascular problems. Because of this, doctors typically will not prescribe Myfembree if you have certain risk factors for these conditions. The risk factors include having:
Another risk factor is smoking and being older than age 35 years.
* For more information about how often this side effect occurred in clinical studies, see Myfembree’s prescribing information.
Symptoms of blood clots
You should call your doctor or seek immediate medical care if you have symptoms of a blood clot. Symptoms of DVTs and PEs can vary, but may include:
If you have questions about your risk of blood clots while taking Myfembree, talk with your doctor.
Bone mineral density describes bone strength. Loss of bone mineral density may occur with Myfembree. Specifically, bone loss in the lower back was reported in some people who took the drug for up to 1 year in clinical studies.*
Decreased bone mineral density or bone loss may lead to osteoporosis (weak and brittle bones) and bone fractures. But it isn’t known if taking Myfembree further increases your risk of future fractures.
It’s not possible to reverse bone loss due to Myfembree by stopping treatment with the drug. Because of this long-term side effect risk, your doctor will likely prescribe Myfembree for no longer than 24 months.
Before and during Myfembree treatment, your doctor may order a bone mineral density test called a DEXA scan. This test checks the strength of your bones.
To help prevent bone loss, your doctor may recommend that you take calcium and vitamin D supplements. Calcium helps strengthen bones and vitamin D helps your body absorb calcium. If you have questions about your risk of bone loss with Myfembree, talk with your doctor.
* For more information about how often this side effect occurred in clinical studies, see Myfembree’s prescribing information.
Hair loss is one of the most common side effects of taking Myfembree. Hair loss and hair thinning were reported as common side effects during the drug’s clinical studies.*
In the studies, some people described their hair loss as moderate. Most people continued to take the drug despite this side effect.
No specific pattern of hair loss has been reported with Myfembree treatment. It isn’t yet known if this side effect can be reversed by stopping treatment with the drug.
If you’re concerned about hair loss with Myfembree, talk with your doctor. They’ll help you consider the pros and cons. If your heavy periods caused by uterine fibroids are severe, the benefit of taking this medication may outweigh the risk of hair loss or thinning. Your doctor may also suggest ways to help prevent or reduce hair loss.
* For more information about how often this side effect occurred in clinical studies, see Myfembree’s prescribing information.
As with most drugs, some people can have an allergic reaction after taking Myfembree. It isn’t clear how often allergic reactions occurred during the drug’s clinical studies.
Symptoms of a mild allergic reaction can include:
A more severe allergic reaction is rare but possible. Symptoms of a severe allergic reaction can include:
Call your doctor right away if you have an allergic reaction to Myfembree, as the reaction could become severe. Call 911 or your local emergency number if your symptoms feel life threatening or if you think you’re having a medical emergency.
The following information describes dosages that are commonly taken or recommended. However, be sure to take the dosage your doctor prescribes for you. Your doctor will determine the best dosage to fit your needs.
Myfembree comes as an oral tablet.
Myfembree is available in one strength that’s a fixed combination of its three active ingredients. Each tablet contains 40 milligrams (mg) of relugolix, 1 mg of estradiol, and 0.5 mg of norethindrone.
The typical dosage of Myfembree is one tablet, once daily. It’s best to take your dose at about the same time each day. This helps keep a steady level of the drug in your system so it can work effectively.
If you take certain medications that interact with Myfembree, it’s important to take your dose of Myfembree at least 6 hours before your other medications. (For more information, see the “Myfembree interactions” section below or ask your pharmacist.)
It’s recommended that you take your first dose of Myfembree as soon as possible after the start of your period. But you can still take the drug within 7 days after your period begins.
If you start taking Myfembree outside of this 7-day window, your period may become heavier or irregular. But this should occur only just after starting treatment. And the bleeding should become lighter by your next period.
If you have questions about when to take Myfembree, talk with your doctor.
If you miss a dose of Myfembree, take it as soon as possible within the same day. Then take your next dose at your usual time the following day. You should not take two doses of Myfembree within the same day to make up for a missed dose.
To help make sure that you don’t miss a dose, try using a medication reminder. This can include setting an alarm or using a timer. You could also download a reminder app on your phone.
Myfembree is meant to be taken as a long-term treatment for a maximum of 24 months. This is because the medication may cause bone loss that can’t be reversed. (For more information about bone loss, see “Side effect details” in the “Myfembree side effects” section above.)
If you and your doctor determine that Myfembree is safe and effective for you, you’ll likely take it for up to 24 months.
Other drugs are available that can treat heavy periods caused by uterine fibroids. Some may be a better fit for you than others. If you’re interested in finding an alternative to Myfembree, talk with your doctor. They can tell you about other medications that may work well for you.
Note: Some of the drugs listed here are used off-label to treat these specific conditions. Off-label drug use is when a drug approved by the Food and Drug Administration (FDA) is used for a purpose other than what it’s approved for.
Examples of other drugs that may be used to treat heavy periods caused by uterine fibroids include:
As with all medications, the cost of Myfembree can vary. The actual price you’ll pay depends on your insurance plan, your location, and the pharmacy you use.
Keep in mind that you may be able to get a 90-day supply of Myfembree. If approved by your insurance company, getting a 90-day supply of the drug could reduce your number of trips to the pharmacy and help lower the cost. If you’re interested in this option, check with your doctor or your insurance company.
Before approving coverage for Myfembree, your insurance company may require you to get prior authorization. This means that your doctor and insurance company will need to communicate about your prescription before the insurance company will cover the drug. The insurance company will review the prior authorization request and decide if the drug will be covered.
If you’re not sure if you’ll need to get prior authorization for Myfembree, contact your insurance company.
If you need financial support to pay for Myfembree, or if you need help understanding your insurance coverage, help is available.
Myovant Sciences GmbH, the manufacturer of Myfembree, offers ways to save on the drug. For more information and to find out if you’re eligible for support, visit its website. There, you can learn more about cost savings based on whether you:
Myfembree may be available through a mail-order pharmacy. Using this service may help lower the drug’s cost and allow you to get your medication without leaving home.
If recommended by your doctor, you may be able to receive a 90-day supply of Myfembree, so there’s less concern about running out of the medication. If you’re interested in this option, check with your doctor and your insurance company. Some Medicare plans may help cover the cost of mail-order medications.
If you don’t have insurance, you can ask your doctor or pharmacist about online pharmacy options.
Myfembree is not available in a generic form. A generic drug is an exact copy of the active drug in a brand-name medication. Generics tend to cost less than brand-name drugs.
Here are answers to some frequently asked questions about Myfembree.
Myfembree doesn’t get rid of or cure uterine fibroids (growths on or in the uterus that aren’t cancer). The medication is used to treat a common symptom of uterine fibroids: heavy periods. Taking Myfembree may help make your periods lighter.
The only cure for heavy periods caused by uterine fibroids is a hysterectomy (surgery to remove your uterus).
Your doctor can provide more information about ways to treat uterine fibroids or manage related symptoms.
No, Myfembree is not a type of birth control, and it does not prevent pregnancy. There are types of birth control that may help lighten periods, but Myfembree isn’t one of them.
Myfembree is used to manage heavy periods caused by uterine fibroids.
It’s important to note that you should use nonhormonal birth control while taking Myfembree. For details, see the “Myfembree and birth control” section below.
If you have questions about using birth control during Myfembree treatment, talk with your doctor or pharmacist.
Yes, you may need certain tests before taking Myfembree, and there are specific instructions about when to start taking the drug.
Before you start treatment with Myfembree, your doctor may have you take a pregnancy test to confirm that you’re not pregnant. The drug is not safe to use in pregnancy. Taking Myfembree while pregnant may increase the risk of pregnancy loss. To learn more, see the “Myfembree and pregnancy” section below.
Your doctor may also order a bone mineral density test called a DEXA scan. This scan checks the strength of your bones. Myfembree may cause bone loss, which can lead to osteoporosis (weak and brittle bones) and an increased risk of bone fractures. For more information about bone loss, see “Side effect details” in the “Myfembree side effects” section above.
There are special instructions for when to start Myfembree. The timing depends on your period. For details, see the “Myfembree dosage” section above.)
If you have additional questions about tests and instructions regarding Myfembree, talk with your doctor.
Alcohol shouldn’t interact with Myfembree.
However, drinking alcohol may increase the risk of certain side effects of Myfembree or make them more severe. These side effects* can include:
If you drink alcohol, talk with your doctor about how much is safe to consume while taking Myfembree.
* For more information about these side effects, see the “Myfembree side effects” section above.
Myfembree has a boxed warning for this side effect. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous.

Myfembree can interact with several other medications.
Different interactions can cause different effects. For instance, some interactions can interfere with how well a drug works. Other interactions can increase the number of side effects or make them more severe.
Below are some medications that can interact with Myfembree. This section does not contain all drugs that may interact with Myfembree.
Before taking Myfembree, talk with your doctor and pharmacist. Tell them about all prescription, over-the-counter, and other drugs you take. Also tell them about any vitamins, herbs, and supplements you use. Sharing this information can help you avoid potential interactions.
If you have questions about drug interactions that may affect you, ask your doctor or pharmacist.
Some medications can reduce the effectiveness of Myfembree or increase the risk of side effects such as blood clots.* Some examples of these medications include:
* Myfembree has a boxed warning about blood clots. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous. To learn more, see “Side effect details” in the “Myfembree side effects” section above.
Taking Myfembree and drugs called P-glycoprotein (P-gp) inhibitors too close together can cause Myfembree to be less effective at treating your condition.
Because of this risk, it’s important to separate doses of P-gp inhibitor drugs from doses of Myfembree. You’ll likely take Myfembree first, then wait at least 6 hours to take your other medications.
Some examples of commonly prescribed P-gp inhibitors include:
There aren’t any herbs or supplements that have been specifically reported to interact with Myfembree. However, you should still check with your doctor or pharmacist before using any of these products while taking Myfembree.
There aren’t any foods that have been specifically reported to interact with Myfembree.
However, grapefruit is known to interact with other medications that contain estrogen. (Myfembree contains estradiol, a type of estrogen.) Consuming grapefruit or grapefruit juice with Myfembree may increase the level of estrogen in your body, which can raise your risk of side effects.*
If you have any questions about eating certain foods with Myfembree, talk with your doctor.
* For more about side effects, see the “Myfembree side effects” section above.
You should take Myfembree according to the instructions your doctor gives you.
Myfembree is an oral tablet that you swallow.
You’ll likely take Myfembree once per day. It’s best to take it at about the same time each day. This helps keep a steady level of the drug in your system so it can work effectively.
If you take certain medications that can interact with Myfembree, you may have to adjust when you take them and Myfembree. For more information, see the “Myfembree interactions” section above or ask your pharmacist.
To help make sure that you don’t miss a dose, try using a medication reminder. This can include setting an alarm or using a timer. You could also download a reminder app on your phone.
You may take Myfembree with or without food.
It isn’t known if it’s safe to crush, split, or chew Myfembree tablets. In clinical studies, the medication was swallowed whole.
If you have trouble swallowing Myfembree tablets, talk with your doctor or pharmacist. They may suggest ways to help you take these tablets or discuss other options with you.
Myfembree is approved to manage heavy periods caused by uterine fibroids. These fibroids are growths on or in the uterus that aren’t cancer. The drug is for use in adult females* who haven’t yet gone through menopause.
It isn’t fully understood what causes uterine fibroids, but it may be related to hormones. Fibroids tend to shrink or swell over time depending on the levels of the sex hormones estrogen and progesterone. When a person’s hormone levels are high, such as during pregnancy, fibroids tend to swell. When a person’s hormone levels are low, such as after menopause, fibroids tend to shrink.
Heavy periods are a common symptom of uterine fibroids.
The hormones estrogen and progesterone play a role in your menstrual cycle and the thickness of the uterus lining. (When the lining sheds, you have your period.) Myfembree works by lowering the levels of estrogen and progesterone in your body. This helps reduce heavy menstrual bleeding.
Myfembree starts to work shortly after you take a dose. So it’s important to start treatment as soon as possible after your period begins. But you can take your first dose within 7 days from when your period starts.
In clinical studies, some females* experienced lighter periods within 4 weeks of Myfembree treatment.
If you don’t notice relief from heavy periods within a few months of taking Myfembree, talk with your doctor.
*Sex and gender exist on spectrums. Use of the term “female” in this article refers to sex assigned at birth.
Myfembree is not safe to take while pregnant or while trying to become pregnant. Taking the drug during pregnancy may cause early pregnancy loss.
Keep in mind that Myfembree may cause changes in your menstrual cycle, such as lighter periods or missed periods. But Myfembree doesn’t prevent pregnancy. Missed periods can be a sign that you’re pregnant.
If you miss periods while taking Myfembree, you should take a pregnancy test. If you’re pregnant, tell your doctor right away. They’ll likely have you stop taking the drug.
If you become pregnant while taking Myfembree, you’re encouraged to join a pregnancy registry. Pregnancy registries help medical professionals collect information about the safety of certain drugs. This information can help you make informed decisions about treatments during pregnancy.
You can learn more by talking with your doctor or calling the Myfembree Pregnancy Exposure Registry at 855-428-0707.
Myfembree is not safe to take while pregnant or while trying to become pregnant.* Taking the medication may increase the risk of early pregnancy loss. If you’re sexually active and you or your partner can become pregnant, talk with your doctor about your birth control needs while you’re taking Myfembree.
While taking Myfembree, you should use effective nonhormonal birth control, such as condoms. You should continue to use nonhormonal birth control for at least 1 week after your last dose of Myfembree.
Hormonal birth control (such as birth control pills, patches, or vaginal rings) should not be used with Myfembree. This is because the combination may increase the risk of estrogen-related side effects, such as blood clots.† The combination may also interact in a way that makes Myfembree less effective than usual.
Before starting Myfembree treatment, be sure to tell your doctor about any birth control you currently use. If it contains hormones, they’ll likely have you switch to nonhormonal birth control before you start taking Myfembree.
* For more information about Myfembree and pregnancy, see the “Myfembree and pregnancy” section above.
Myfembree has a boxed warning about blood clots. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous. To learn more, see “Side effect details” in the “Myfembree side effects” section above.

Your doctor will likely recommend that you don’t take Myfembree while you’re breastfeeding. Although the drug hasn’t been studied in people who were breastfeeding, research in animals showed that Myfembree is likely to pass into breast milk. The drug’s effects on a child who is breastfed aren’t known.
If you’re breastfeeding or planning to breastfeed, tell your doctor before starting Myfembree. They’ll talk with you about your options, including other ways to manage heavy periods.
This drug comes with several precautions.
Myfembree has a boxed warning. This is the most serious warning from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients about drug effects that may be dangerous.
Myfembree contains forms of the hormones estrogen and progestin. Medications that contain these hormones are known to increase the risk of blood clots and cardiovascular disorders. (The term cardiovascular means related to the heart and blood vessels.) Types of blood clots that may occur include deep vein thrombosis and pulmonary embolism. These blood clots can cause serious cardiovascular problems such as a heart attack or stroke.
Because of this risk, doctors typically will not prescribe Myfembree if you have certain risk factors for these conditions. The risk factors include:
For more information about this boxed warning, see “Side effect details” in the “Myfembree side effects” section above.
Before taking Myfembree, talk with your doctor about your health history. Myfembree may not be right for you if you have certain medical conditions or other factors affecting your health. These include:
* For more information, see “Side effect details” in the “Myfembree side effects” section above.
Taking more than the recommended dosage of Myfembree can lead to serious side effects. Do not take more Myfembree than your doctor recommends.
Myfembree contains a form of estrogen and a form of progestin. An overdose of these hormones can cause symptoms such as:
If you think you’ve taken too much of this drug, call your doctor. You can also call the American Association of Poison Control Centers at 800-222-1222 or use its online tool. But if your symptoms are severe, call 911 or your local emergency number, or go to the nearest emergency room right away.
When you get Myfembree from the pharmacy, the pharmacist will add an expiration date to the label on the bottle. This date is typically 1 year from the date they dispensed the medication.
The expiration date helps guarantee that the medication is effective during this time. The current stance of the Food and Drug Administration (FDA) is to avoid using expired medications. If you have unused medication that has gone past the expiration date, talk with your pharmacist about whether you might still be able to take it.
How long a medication remains good to use can depend on many factors, including how and where you store the medication.
You should store Myfembree tablets at room temperature, 59°F to 86°F (15°C to 30°C), in a tightly sealed container away from light. Avoid storing this medication in areas where it could get damp or wet, such as bathrooms.
If you no longer need to take Myfembree and have leftover medication, it’s important to dispose of it safely. This helps prevent others, including children and pets, from taking the drug by accident. It also helps keep the drug from harming the environment.
This article provides several useful tips on medication disposal. You can also ask your pharmacist for information about how to dispose of your medication.
Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.





OUR BRANDS

source

Posted on Leave a comment

Tiktoker Peller Apologizes For Calling Afrobeats Star Runtown "Up-And-Coming Artist" – gistlover.com


Popular TikToker Peller has publicly apologized following intense backlash over his controversial remarks about Nigerian Afrobeats star Runtown.
During a recent livestream, Peller referred to Runtown as an “up-and-coming artist,” downplaying the singer’s achievements and influence in the industry. His statement was met with swift criticism from fans and fellow musicians, who defended Runtown’s well-established career.
Realizing his mistake, Peller returned to livestreaming—this time alongside his girlfriend, Jarvis—to express his sincere regret. He admitted that his lack of awareness and youthful ignorance had caused him to misjudge Runtown’s contributions to music.
Peller further explained that he was too young to have fully experienced Runtown’s rise to stardom and acknowledged the artist’s significant impact on Afrobeats. With humility, he took responsibility for his words and asked for forgiveness from both Runtown and his fans.
“When I was hearing Runtown’s music, I was too young… Please, forgive the poor boy. Let him breathe. God won’t shame us. I’m sorry, my brothers and sisters.”
See video below:
In other news, A widely circulated video captures the intense moment when TikTok sensation Jarvis, known for her AI-driven content, confronts Peller over his remarks about her family.
Jarvis, who recently marked her birthday with Peller’s extravagant gifts, appeared upset in the footage. During their exchange, she threatens to reconsider their marriage plans, prompting Peller to remind her of the many things he has done for her and her family.
His comments only escalate the situation, leading Jarvis to sternly warn him against speaking negatively about her loved ones. In response, Peller questions whether she, too, would refrain from making similar remarks about his lineage.

Copyright © 2025 Gistlover Media. All Rights Reserved

source

Posted on Leave a comment

Ripple’s Brad Garlinghouse Says XRP Could Make the List of U.S. Government Asset Stockpile – TradingView

Ripple's Brad Garlinghouse Isn't Taking His Feet Off SEC's Neck Anytime Soon For XRP’s Struggles

Ripple CEO Brad Garlinghouse has expressed confidence that XRP will be included in the U.S. government’s upcoming digital asset stockpile.
Select market data provided by ICE Data Services. Select reference data provided by FactSet. Copyright © 2025 FactSet Research Systems Inc.Copyright © 2025, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC fillings and other documents provided by Quartr.© 2025 TradingView, Inc.

source